Iran Unveils Nuclear Ointment for Skin Cancer Treatment
WANA (Feb 03) – Iranian scientists have successfully developed an innovative radiopharmaceutical ointment for the treatment of skin cancer, placing Iran among the world’s leading and limited number of countries possessing this advanced medical technology.
Mohammad Eslami, Head of the Atomic Energy Organization of Iran, announced that the country has produced a radiopharmaceutical specifically designed to treat skin cancer. After completing research and clinical trial phases, the drug has now been officially added to Iran’s national pharmaceutical portfolio and is available to patients.
Skin cancer is one of the most common types of cancer worldwide and is typically treated through surgery, chemotherapy, or radiotherapy. While these methods can be effective, they are often associated with significant side effects, pain, and lengthy treatment periods. The newly developed Iranian technology offers a different, less invasive therapeutic approach.
The ointment is based on radiopharmaceuticals—substances containing radioactive isotopes capable of directly targeting cancerous cells. In this method, radiation is delivered locally, destroying cancer cells while largely preserving surrounding healthy tissue.
Transforming the radiopharmaceutical into a topical ointment allows for safer, easier, and more precise application. This innovation has the potential to significantly reduce the need for extensive surgeries or aggressive treatments.
According to Eslami, clinical results have been highly promising, and the effectiveness of the drug has been scientifically validated.
Medical experts believe this breakthrough can simplify the treatment process for skin cancer patients, reduce pain and side effects, and enable patients to maintain their daily routines with improved quality of life.
The introduction of this ointment into clinical treatment marks an important step toward enhancing patient outcomes and increasing life expectancy.
This achievement represents a practical and peaceful application of nuclear technology in the healthcare sector and highlights Iran’s growing scientific and technological capacity to develop advanced medical treatments at an international level.
The Three Pillars of the Iranian Nuclear Program’s Resilience
WANA (Nov 14) – Following the recent attacks on Iran’s nuclear facilities, Tehran has emphasized a renewed narrative: even if infrastructure is damaged, knowledge cannot be destroyed. Iranian officials argue that what keeps the nuclear program intact is not buildings and equipment, but three foundational components—indigenous expertise, a vast human-resource network, and the deep integration […]
